Inventor

ROTH BRUCE DAVID

US35 patents

⚠️ This page may combine multiple inventors who share the name “ROTH BRUCE DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROTH BRUCE DAVID

WARNER LAMBERT CO

Compounds for and methods of inhibiting matrix metalloproteinases

N-acyl sulfamic acid esters useful as hypocholesterolemic agents

Phosphonamide ACAT inhibitors

Sulfonyl urea and carbamate ACAT inhibitors

Benzimidazole compounds useful for the treatment of inflammatory disease, atherosclerosis, restenosis or inhibiting lipoxygenase

Heterocyclic-substituted alkyl amide acat inhibitors

Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases

Fluorinated butyric acids and their derivatives as inhibitors of matrix metalloproteinases

2-phenyl benzimidazole derivatives as MCP-1 antagonists

Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases

Sulfhydryl containing peptides for treating vascular disease

Peptidyl calcium channel blockers

Pyrazolone derivatives as MCP-1 antagonists

Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases

Amide inhibitors of microsomal triglyceride transfer protein

Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis

Cholecystokinin antagonists, their preparation and therapeutic use

Phosphonamide ACAT inhibitors

Tetrazole alkyl amide acat inhibitors

Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases

Flourine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases

Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases

Phenyl glycine compounds and methods of treating atherosclerosis and restenosis

Sulfonamide compounds and methods of treating atherosclerosis and restenosis

Sulfonamide compounds and methods of treating atherosclerosis and restenosis

MILLENNIUM PHARM INC

Substituted quinoxaline derivatives as interleukin-8 receptor antagonists

2-phenyl benzimidazole derivatives as MCP-1 antagonists

Chemokine receptor antagonists

Thiazolidinone compounds useful as chemokine inhibitors

2-phenyl benzimidazole derivatives as MCP-1 antagonists

Aryl alkenamides derivatives as MCP-1 antagonists

(unassigned)

Substituted diarylalkyl amides as calcium channel antagonists

Isothiazolones lower plasma levels of lipoprotein(a)

BASF AG

Sulfonamide interleukin-1β converting enzyme inhibitors

PFIZER

Pyrrole-based HMG-CoA reductase inhibitors